Innovent Biologics (HK:1801) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovent Biologics, a biopharmaceutical company, has announced changes to its board committees, effective August 30, 2024. Dr. De-Chao Michael Yu has transitioned from chairman to member of the Nomination Committee, stepping down from the Remuneration Committee. Mr. Shuyun Chen moves from member to chairman of the Nomination Committee and joins the Audit Committee.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.